Organization · Private Equity
BioScience Managers
BioScience Managers is an international healthcare investment firm focused on transformative advancements in life sciences and digital technology. They combine global investment opportunities with local expertise to support innovative companies.
Overview
What BioScience Managers does
What BioScience Managers is
BioScience Managers is an international healthcare investment firm focused on transformative advancements in life sciences and digital technology. They combine global investment opportunities with local expertise to support innovative companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2003
- Approximate age
- About 23 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find BioScience Managers elsewhere
Open the official website or a supported primary organization account.
Capability profile
BioScience Managers as a funder
Investment thesis
BioScience Managers focuses on financing and supporting innovative science and technology aimed at transforming healthcare, particularly in areas with significant unmet medical needs.
Focus narrative
BioScience Managers invests in various sectors within healthcare, including genomic medicine, pediatrics, and digital technologies. The firm emphasizes personalized medicine through genomic insights, targets chronic conditions in children, and supports technologies that enhance access to care and patient engagement.
Value beyond capital
BioScience Managers adds value to its portfolio companies by providing strategic support and expertise in the commercialization of biomedical innovations, particularly through its management of the Biomedical Translation Fund.
Focus and fit
- Regions
- Global · Oceania
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 11
Portfolio context
Notable portfolio companies include Acrux, which develops pharmaceutical products for global markets; Adherium, focusing on digital health technologies for medication adherence; Calcimedica, which develops drugs for inflammatory diseases; and Canary Medical, known for medical implant and data management devices. Other companies include Cynata Therapeutics, Humanetix, Immunosis, Pharmamark, Provider Assist, Rex Bionics, Saluda Medical, and SeaDragon.
Common questions
What to know about BioScience Managers
Upseed classifies BioScience Managers under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.